Review



plasmid 8xgtiic luciferase  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Addgene inc plasmid 8xgtiic luciferase
    Plasmid 8xgtiic Luciferase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 360 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/8xGTIIC-luciferase+(Plasmid+%2334615)/pmc13748912-307-1-9
    Average 96 stars, based on 360 article reviews
    plasmid 8xgtiic luciferase - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    other:

    Article Title: Encapsulation of mRNA in Therapeutics Like Lipid Nanoparticles Probed by Deep-UV Resonance Raman Spectroscopy
    Article Snippet: Plasmid pTK305 encoding firefly luciferase was obtained from Addgene (#66812).

    Article Title: Architecture of the Norrin signaling complex and structure-guided surrogate design.
    Article Snippet: Norrin binds Frizzled 4 (FZD4), tetraspanin 12 (TSPAN12) and low-density lipoprotein receptor-related protein 5 (LRP5) to regulate angiogenesis and the integrity of the blood–brain barrier and inner blood–retina barrier (BRB).. Aberrant Norrin signal causes retinopathies, BRB defects and deafness.. Therapeutic mimetics of Norrin are currently in clinical trials for eye diseases.

    Article Title: Encapsulation of mRNA in Therapeutics Like Lipid Nanoparticles Probed by Deep-UV Resonance Raman Spectroscopy.
    Article Snippet: Plasmid pTK305 encoding firefly luciferase was obtained from Addgene (#66812).

    Article Title: Targeting Hippo-MAPK crosstalk in schwannoma: Overcoming resistance with dual inhibition
    Article Snippet: To enable longitudinal bioluminescence imaging, mouse schwannoma cells were first stably transduced with a retroviral construct expressing firefly luciferase (MSCV Luciferase PGK-hygro, Addgene, plasmid # 18782).

    Article Title: Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening
    Article Snippet: As negative controls, we used the lentiviral HCRed (Addgene, Watertown, MA, USA, 25892) and luciferase (Addgene, Watertown, MA, USA, 25894).

    Article Title: Syk activation during FcγR-mediated phagocytosis involves Syk palmitoylation and desulfenylation.
    Article Snippet: Control vectors targeting firefly luciferase were obtained from Addgene (# 80248/80173/80261).

    Article Title: Syk activation during FcγR-mediated phagocytosis involves Syk palmitoylation and desulfenylation
    Article Snippet: Control vectors targeting firefly luciferase were obtained from Addgene (# 80248/80173/80261).

    Cell Culture:

    Article Title: NoxO1 promotes endosome formation and reduces intracellular vesicle processing
    Article Snippet: The Bright GloTM Luciferase Assay System (#E2610, Promega) was performed according to the manufacturer's protocol. .. Cells were cultured on white 96-well plates with flat transparent bottom and transfected with reporter plasmids either coding for the CLEAR promoter sequence coupled to firefly luciferase (#66800, addgene) or constitutively active renilla luciferase or empty PGL4-vector backbone. .. The Bright Glo Luciferase Assay System (#E2610, Promega) was performed according to the manufacturer's protocol.

    Transfection:

    Article Title: NoxO1 promotes endosome formation and reduces intracellular vesicle processing
    Article Snippet: The Bright GloTM Luciferase Assay System (#E2610, Promega) was performed according to the manufacturer's protocol. .. Cells were cultured on white 96-well plates with flat transparent bottom and transfected with reporter plasmids either coding for the CLEAR promoter sequence coupled to firefly luciferase (#66800, addgene) or constitutively active renilla luciferase or empty PGL4-vector backbone. .. The Bright Glo Luciferase Assay System (#E2610, Promega) was performed according to the manufacturer's protocol.

    Sequencing:

    Article Title: NoxO1 promotes endosome formation and reduces intracellular vesicle processing
    Article Snippet: The Bright GloTM Luciferase Assay System (#E2610, Promega) was performed according to the manufacturer's protocol. .. Cells were cultured on white 96-well plates with flat transparent bottom and transfected with reporter plasmids either coding for the CLEAR promoter sequence coupled to firefly luciferase (#66800, addgene) or constitutively active renilla luciferase or empty PGL4-vector backbone. .. The Bright Glo Luciferase Assay System (#E2610, Promega) was performed according to the manufacturer's protocol.

    Luciferase:

    Article Title: NoxO1 promotes endosome formation and reduces intracellular vesicle processing
    Article Snippet: The Bright GloTM Luciferase Assay System (#E2610, Promega) was performed according to the manufacturer's protocol. .. Cells were cultured on white 96-well plates with flat transparent bottom and transfected with reporter plasmids either coding for the CLEAR promoter sequence coupled to firefly luciferase (#66800, addgene) or constitutively active renilla luciferase or empty PGL4-vector backbone. .. The Bright Glo Luciferase Assay System (#E2610, Promega) was performed according to the manufacturer's protocol.



    Similar Products

    98
    Vazyme Biotech Co dual luciferase reporter assay system
    Dual Luciferase Reporter Assay System, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/Dual+Luciferase+Reporter+Assay+Kit/pmc13752233-243-19-23
    Average 98 stars, based on 1 article reviews
    dual luciferase reporter assay system - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology dual luciferase reporter gene luminescence assay kit
    Dual Luciferase Reporter Gene Luminescence Assay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/Dual+Luciferase+Reporter+Gene+Luminescence+Assay+Kit/pm42189366-167-16-24
    Average 94 stars, based on 1 article reviews
    dual luciferase reporter gene luminescence assay kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Vazyme Biotech Co duo lite luciferase
    Duo Lite Luciferase, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/Duo-Lite+Luciferase+Assay+System/pm43003165-132-11-19
    Average 96 stars, based on 1 article reviews
    duo lite luciferase - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Vazyme Biotech Co clt lysis buffer
    Clt Lysis Buffer, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/Dual+Luciferase+Reporter+Assay+Kit/pmc13762209-89-8-25
    Average 98 stars, based on 1 article reviews
    clt lysis buffer - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    96
    Addgene inc plasmid 8xgtiic luciferase
    Plasmid 8xgtiic Luciferase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/8xGTIIC-luciferase+(Plasmid+%2334615)/pmc13748912-307-1-9
    Average 96 stars, based on 1 article reviews
    plasmid 8xgtiic luciferase - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Vazyme Biotech Co luciferase substrate
    Luciferase Substrate, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/Bio-Lite+Luciferase+Assay+System/pm43003801-307-0-4
    Average 96 stars, based on 1 article reviews
    luciferase substrate - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Vazyme Biotech Co dual luciferase reporter assay kit
    Dual Luciferase Reporter Assay Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/Dual+Luciferase+Reporter+Assay+Kit/pmc13748688-295-13-17
    Average 98 stars, based on 1 article reviews
    dual luciferase reporter assay kit - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    96
    Addgene inc yap taz responsive reporter 8xgtiic luciferase
    RBBP5 facilitates YAP1 activation by suppressing WNT5A expression a and b Gene set enrichment analysis (GSEA) of RNA-seq data revealing signaling pathways and gene signatures altered by RBBP5 knockdown in HCC-1143 cells. c Heatmap displaying differentially expressed genes (≥1.25-fold) with tumor-promoting or tumor-suppressive roles in HCC-1143 cells following RBBP5 knockdown. d qRT-PCR validation of RBBP5-regulated genes identified by RNA-seq. Data are presented as mean ± SD from three technical replicates. Statistical significance was determined using two-tailed Student’s t-tests. *** p < 0.001 compared to the control. shCON, shRNA control; shRBBP5, RBBP5 knockdown. e Western blot showing the expression of WNT5A and key components of the Hippo signaling pathway in HCC-1428 and HCC-1143 cells. CONN, empty vector; RBBP5, RBBP5 overexpression; shCON, shRNA control; shRBBP5, RBBP5 knockdown. f qRT-PCR was performed to assess the mRNA levels of YAP1 target genes in HCC-1428 and HCC-1143 cells. Data are shown as mean ± SD from three technical replicates. Statistical significance was determined using two-tailed Student’s t-tests for HCC-1428 cells and one-way ANOVA followed by an LSD post hoc test for HCC-1143 cells. *** p < 0.001 compared to the controls (CONN or shCON). g Luciferase assay for YAP1/TAZ transcriptional activity. HCC-1428 and HCC-1143 cells were transfected with the YAP1/TAZ-responsive reporter <t>(8xGTIIC-luciferase)</t> for 24 h, followed by a luciferase assay to assess transcriptional activity. Luciferase activity was normalized to β -galactosidase activity. Data represents mean ± SD from three independent experiments. Statistical analysis was conducted using two-tailed Student’s t-tests for HCC-1428 cells and one-way ANOVA with an LSD post hoc test for HCC-1143 cells. *** p < 0.001 compared to the controls (CONN or shCON). h Cytoplasmic and nuclear fractionation was performed to evaluate the nuclear translocation of YAP1 in the indicated cell lines. SP1 and α -tubulin were used as nuclear and cytoplasmic markers, respectively, to confirm fractionation purity.
    Yap Taz Responsive Reporter 8xgtiic Luciferase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/8xGTIIC-luciferase+(Plasmid+%2334615)/pmc13757685-205-5-11
    Average 96 stars, based on 1 article reviews
    yap taz responsive reporter 8xgtiic luciferase - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Addgene inc luciferase gene
    RBBP5 facilitates YAP1 activation by suppressing WNT5A expression a and b Gene set enrichment analysis (GSEA) of RNA-seq data revealing signaling pathways and gene signatures altered by RBBP5 knockdown in HCC-1143 cells. c Heatmap displaying differentially expressed genes (≥1.25-fold) with tumor-promoting or tumor-suppressive roles in HCC-1143 cells following RBBP5 knockdown. d qRT-PCR validation of RBBP5-regulated genes identified by RNA-seq. Data are presented as mean ± SD from three technical replicates. Statistical significance was determined using two-tailed Student’s t-tests. *** p < 0.001 compared to the control. shCON, shRNA control; shRBBP5, RBBP5 knockdown. e Western blot showing the expression of WNT5A and key components of the Hippo signaling pathway in HCC-1428 and HCC-1143 cells. CONN, empty vector; RBBP5, RBBP5 overexpression; shCON, shRNA control; shRBBP5, RBBP5 knockdown. f qRT-PCR was performed to assess the mRNA levels of YAP1 target genes in HCC-1428 and HCC-1143 cells. Data are shown as mean ± SD from three technical replicates. Statistical significance was determined using two-tailed Student’s t-tests for HCC-1428 cells and one-way ANOVA followed by an LSD post hoc test for HCC-1143 cells. *** p < 0.001 compared to the controls (CONN or shCON). g Luciferase assay for YAP1/TAZ transcriptional activity. HCC-1428 and HCC-1143 cells were transfected with the YAP1/TAZ-responsive reporter <t>(8xGTIIC-luciferase)</t> for 24 h, followed by a luciferase assay to assess transcriptional activity. Luciferase activity was normalized to β -galactosidase activity. Data represents mean ± SD from three independent experiments. Statistical analysis was conducted using two-tailed Student’s t-tests for HCC-1428 cells and one-way ANOVA with an LSD post hoc test for HCC-1143 cells. *** p < 0.001 compared to the controls (CONN or shCON). h Cytoplasmic and nuclear fractionation was performed to evaluate the nuclear translocation of YAP1 in the indicated cell lines. SP1 and α -tubulin were used as nuclear and cytoplasmic markers, respectively, to confirm fractionation purity.
    Luciferase Gene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luciferase/pCAG%2FLuci+(Plasmid+%23139981)/pm42995494-165-17-26
    Average 94 stars, based on 1 article reviews
    luciferase gene - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    RBBP5 facilitates YAP1 activation by suppressing WNT5A expression a and b Gene set enrichment analysis (GSEA) of RNA-seq data revealing signaling pathways and gene signatures altered by RBBP5 knockdown in HCC-1143 cells. c Heatmap displaying differentially expressed genes (≥1.25-fold) with tumor-promoting or tumor-suppressive roles in HCC-1143 cells following RBBP5 knockdown. d qRT-PCR validation of RBBP5-regulated genes identified by RNA-seq. Data are presented as mean ± SD from three technical replicates. Statistical significance was determined using two-tailed Student’s t-tests. *** p < 0.001 compared to the control. shCON, shRNA control; shRBBP5, RBBP5 knockdown. e Western blot showing the expression of WNT5A and key components of the Hippo signaling pathway in HCC-1428 and HCC-1143 cells. CONN, empty vector; RBBP5, RBBP5 overexpression; shCON, shRNA control; shRBBP5, RBBP5 knockdown. f qRT-PCR was performed to assess the mRNA levels of YAP1 target genes in HCC-1428 and HCC-1143 cells. Data are shown as mean ± SD from three technical replicates. Statistical significance was determined using two-tailed Student’s t-tests for HCC-1428 cells and one-way ANOVA followed by an LSD post hoc test for HCC-1143 cells. *** p < 0.001 compared to the controls (CONN or shCON). g Luciferase assay for YAP1/TAZ transcriptional activity. HCC-1428 and HCC-1143 cells were transfected with the YAP1/TAZ-responsive reporter (8xGTIIC-luciferase) for 24 h, followed by a luciferase assay to assess transcriptional activity. Luciferase activity was normalized to β -galactosidase activity. Data represents mean ± SD from three independent experiments. Statistical analysis was conducted using two-tailed Student’s t-tests for HCC-1428 cells and one-way ANOVA with an LSD post hoc test for HCC-1143 cells. *** p < 0.001 compared to the controls (CONN or shCON). h Cytoplasmic and nuclear fractionation was performed to evaluate the nuclear translocation of YAP1 in the indicated cell lines. SP1 and α -tubulin were used as nuclear and cytoplasmic markers, respectively, to confirm fractionation purity.

    Journal: Cancer Biology & Therapy

    Article Title: RBBP5 drives cancer stem cell-like characteristics by suppressing the hippo signaling pathway through WNT5A downregulation in breast cancer

    doi: 10.1080/15384047.2026.2756150

    Figure Lengend Snippet: RBBP5 facilitates YAP1 activation by suppressing WNT5A expression a and b Gene set enrichment analysis (GSEA) of RNA-seq data revealing signaling pathways and gene signatures altered by RBBP5 knockdown in HCC-1143 cells. c Heatmap displaying differentially expressed genes (≥1.25-fold) with tumor-promoting or tumor-suppressive roles in HCC-1143 cells following RBBP5 knockdown. d qRT-PCR validation of RBBP5-regulated genes identified by RNA-seq. Data are presented as mean ± SD from three technical replicates. Statistical significance was determined using two-tailed Student’s t-tests. *** p < 0.001 compared to the control. shCON, shRNA control; shRBBP5, RBBP5 knockdown. e Western blot showing the expression of WNT5A and key components of the Hippo signaling pathway in HCC-1428 and HCC-1143 cells. CONN, empty vector; RBBP5, RBBP5 overexpression; shCON, shRNA control; shRBBP5, RBBP5 knockdown. f qRT-PCR was performed to assess the mRNA levels of YAP1 target genes in HCC-1428 and HCC-1143 cells. Data are shown as mean ± SD from three technical replicates. Statistical significance was determined using two-tailed Student’s t-tests for HCC-1428 cells and one-way ANOVA followed by an LSD post hoc test for HCC-1143 cells. *** p < 0.001 compared to the controls (CONN or shCON). g Luciferase assay for YAP1/TAZ transcriptional activity. HCC-1428 and HCC-1143 cells were transfected with the YAP1/TAZ-responsive reporter (8xGTIIC-luciferase) for 24 h, followed by a luciferase assay to assess transcriptional activity. Luciferase activity was normalized to β -galactosidase activity. Data represents mean ± SD from three independent experiments. Statistical analysis was conducted using two-tailed Student’s t-tests for HCC-1428 cells and one-way ANOVA with an LSD post hoc test for HCC-1143 cells. *** p < 0.001 compared to the controls (CONN or shCON). h Cytoplasmic and nuclear fractionation was performed to evaluate the nuclear translocation of YAP1 in the indicated cell lines. SP1 and α -tubulin were used as nuclear and cytoplasmic markers, respectively, to confirm fractionation purity.

    Article Snippet: For the luciferase assay, the YAP/TAZ-responsive reporter 8xGTIIC-luciferase was obtained from Addgene (plasmid #34615).

    Techniques: Activation Assay, Expressing, Gene Set Enrichment Analysis, RNA Sequencing, Protein-Protein interactions, Knockdown, Quantitative RT-PCR, Biomarker Discovery, Two Tailed Test, Control, shRNA, Western Blot, Plasmid Preparation, Over Expression, Luciferase, Activity Assay, Transfection, Analysis, Fractionation, Translocation Assay

    Altering YAP1 activity counteracts the changes in cancer stem cell characteristics induced by RBBP5. a Western blot analysis of lysates from HCC-1428 cells treated with DMSO (vehicle) or 0.5 μM verteporfin for 24 h (left). Western blot analysis of lysates from HCC-1143 cells treated with DMSO (vehicle) or 1 μM XMU-MP-1 for 24 h (right). CONN, empty vector; RBBP5, RBBP5 overexpression; shCON, shRNA control; shRBBP5, RBBP5 knockdown. b Luciferase assay for YAP1/TAZ transcriptional activity. HCC-1428 and HCC-1143 cells were transfected with the YAP1/TAZ-responsive reporter (8xGTIIC-luciferase) for 24 h. HCC-1428 cells were then treated with DMSO (vehicle) or 0.5 μM verteporfin for 24 h, while HCC-1143 cells were treated with DMSO (vehicle) or 1 μM XMU-MP-1 (MST1/2 inhibitor) for 24 h. Data are presented as means ± SD from three independent experiments. p -values were determined by one-way ANOVA followed by a post hoc LSD test. *** p < 0.001. c Representative flow cytometry plots and quantification of cell populations with high ALDH activity in the indicated cells. HCC-1428 cells were treated with DMSO (vehicle) or 0.5 μM verteporfin for 24 h, and HCC-1143 cells were treated with DMSO (vehicle) or 1 μM XMU-MP-1 (MST1/2 inhibitor) for 24 h. Following treatment, ALDH activity was assessed using the ALDEFLUOR assay. Data are presented as means ± SD from three independent experiments. p -values were determined by one-way ANOVA followed by a post hoc LSD test. *** p < 0.001. CONN, control; RBBP5, RBBP5 overexpression; siCON, siRNA control; siRBBP5, RBBP5 siRNA; with DEAB, DEAB-treated samples; without DEAB, samples not treated with DEAB. d Tumorsphere formation in response to verteporfin or XMU-MP-1 treatment. HCC-1428 cells were treated with DMSO (vehicle) or 0.2 μM verteporfin, and HCC-1143 cells were treated with DMSO (vehicle) or 0.5 μM XMU-MP-1 (MST1/2 inhibitor). Representative images of tumorspheres are shown. scale bars, 100 μm. Quantification data represent the mean ± SD of three biological replicates. Statistical analysis was performed using one-way ANOVA with post hoc LSD tests. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Cancer Biology & Therapy

    Article Title: RBBP5 drives cancer stem cell-like characteristics by suppressing the hippo signaling pathway through WNT5A downregulation in breast cancer

    doi: 10.1080/15384047.2026.2756150

    Figure Lengend Snippet: Altering YAP1 activity counteracts the changes in cancer stem cell characteristics induced by RBBP5. a Western blot analysis of lysates from HCC-1428 cells treated with DMSO (vehicle) or 0.5 μM verteporfin for 24 h (left). Western blot analysis of lysates from HCC-1143 cells treated with DMSO (vehicle) or 1 μM XMU-MP-1 for 24 h (right). CONN, empty vector; RBBP5, RBBP5 overexpression; shCON, shRNA control; shRBBP5, RBBP5 knockdown. b Luciferase assay for YAP1/TAZ transcriptional activity. HCC-1428 and HCC-1143 cells were transfected with the YAP1/TAZ-responsive reporter (8xGTIIC-luciferase) for 24 h. HCC-1428 cells were then treated with DMSO (vehicle) or 0.5 μM verteporfin for 24 h, while HCC-1143 cells were treated with DMSO (vehicle) or 1 μM XMU-MP-1 (MST1/2 inhibitor) for 24 h. Data are presented as means ± SD from three independent experiments. p -values were determined by one-way ANOVA followed by a post hoc LSD test. *** p < 0.001. c Representative flow cytometry plots and quantification of cell populations with high ALDH activity in the indicated cells. HCC-1428 cells were treated with DMSO (vehicle) or 0.5 μM verteporfin for 24 h, and HCC-1143 cells were treated with DMSO (vehicle) or 1 μM XMU-MP-1 (MST1/2 inhibitor) for 24 h. Following treatment, ALDH activity was assessed using the ALDEFLUOR assay. Data are presented as means ± SD from three independent experiments. p -values were determined by one-way ANOVA followed by a post hoc LSD test. *** p < 0.001. CONN, control; RBBP5, RBBP5 overexpression; siCON, siRNA control; siRBBP5, RBBP5 siRNA; with DEAB, DEAB-treated samples; without DEAB, samples not treated with DEAB. d Tumorsphere formation in response to verteporfin or XMU-MP-1 treatment. HCC-1428 cells were treated with DMSO (vehicle) or 0.2 μM verteporfin, and HCC-1143 cells were treated with DMSO (vehicle) or 0.5 μM XMU-MP-1 (MST1/2 inhibitor). Representative images of tumorspheres are shown. scale bars, 100 μm. Quantification data represent the mean ± SD of three biological replicates. Statistical analysis was performed using one-way ANOVA with post hoc LSD tests. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: For the luciferase assay, the YAP/TAZ-responsive reporter 8xGTIIC-luciferase was obtained from Addgene (plasmid #34615).

    Techniques: Activity Assay, Stem Cell, Western Blot, Analysis, Plasmid Preparation, Over Expression, shRNA, Control, Knockdown, Luciferase, Transfection, Flow Cytometry